D4T 20 MG Oral Capsule
- RxCUI
- 313108
- RxNorm name
- D4T 20 MG Oral Capsule
- Display name
- D4T 20 MG Oral Capsule
- Full name
- D4T 20 MG Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:07
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 8bb73c56-74cb-4602-b9a3-57bd1082b434 | stavudine 20 MG Oral Capsule [PSN] · stavudine 20 MG Oral Capsule [SCD] · D4T 20 MG Oral Capsule [SY] · DHT 20 MG Oral Capsule [SY] | 4 | 3 | ZERIT ® (stavudine) Capsules ZERIT ® (stavudine) for Oral Solution | 20100812 |
| 7501de1e-149d-405e-94f6-da4010952adf | stavudine 20 MG Oral Capsule [PSN] · stavudine 20 MG Oral Capsule [SCD] · D4T 20 MG Oral Capsule [SY] · DHT 20 MG Oral Capsule [SY] | 4 | 1 | These highlights do not include all the information needed to use stavudine safely and effectively. See full prescribing information for stavudine capsules. Stavudine Capsules, USP Initial U.S. Approval: 1994 | 20130930 |